Cargando…

Progress of Artificial Intelligence in Gynecological Malignant Tumors

Artificial intelligence (AI) is a sort of new technical science which can simulate, extend and expand human intelligence by developing theories, methods and application systems. In the last five years, the application of AI in medical research has become a hot topic in modern science and technology....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jie, Zeng, Zhi Ying, Li, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751777/
https://www.ncbi.nlm.nih.gov/pubmed/33364831
http://dx.doi.org/10.2147/CMAR.S279990
_version_ 1783625724889923584
author Zhou, Jie
Zeng, Zhi Ying
Li, Li
author_facet Zhou, Jie
Zeng, Zhi Ying
Li, Li
author_sort Zhou, Jie
collection PubMed
description Artificial intelligence (AI) is a sort of new technical science which can simulate, extend and expand human intelligence by developing theories, methods and application systems. In the last five years, the application of AI in medical research has become a hot topic in modern science and technology. Gynecological malignant tumors involves a wide range of knowledge, and AI can play an important part in these aspects, such as medical image recognition, auxiliary diagnosis, drug research and development, treatment scheme formulation and other fields. The purpose of this paper is to describe the progress of AI in gynecological malignant tumors and discuss some problems in its application. It is believed that AI improves the efficiency of diagnosis, reduces the burden of clinicians, and improves the effect of treatment and prognosis. AI will play an irreplaceable role in the field of gynecological malignant oncology and will promote the development of medicine and further promote the transformation from traditional medicine to precision medicine and preventive medicine. However, there are also some problems in the application of AI in gynecologic malignant tumors. For example, AI, inseparable from human participation, still needs to be more “humanized”, and needs to further protect patients’ privacy and health, improve legal and insurance protection, and further improve according to local ethnic conditions and national conditions. However, it is believed that with the continuous development of AI, especially ensemble classifier, and deep learning will have a profound influence on the future of medical technology, which is a powerful driving force for future medical innovation and reform.
format Online
Article
Text
id pubmed-7751777
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77517772020-12-22 Progress of Artificial Intelligence in Gynecological Malignant Tumors Zhou, Jie Zeng, Zhi Ying Li, Li Cancer Manag Res Review Artificial intelligence (AI) is a sort of new technical science which can simulate, extend and expand human intelligence by developing theories, methods and application systems. In the last five years, the application of AI in medical research has become a hot topic in modern science and technology. Gynecological malignant tumors involves a wide range of knowledge, and AI can play an important part in these aspects, such as medical image recognition, auxiliary diagnosis, drug research and development, treatment scheme formulation and other fields. The purpose of this paper is to describe the progress of AI in gynecological malignant tumors and discuss some problems in its application. It is believed that AI improves the efficiency of diagnosis, reduces the burden of clinicians, and improves the effect of treatment and prognosis. AI will play an irreplaceable role in the field of gynecological malignant oncology and will promote the development of medicine and further promote the transformation from traditional medicine to precision medicine and preventive medicine. However, there are also some problems in the application of AI in gynecologic malignant tumors. For example, AI, inseparable from human participation, still needs to be more “humanized”, and needs to further protect patients’ privacy and health, improve legal and insurance protection, and further improve according to local ethnic conditions and national conditions. However, it is believed that with the continuous development of AI, especially ensemble classifier, and deep learning will have a profound influence on the future of medical technology, which is a powerful driving force for future medical innovation and reform. Dove 2020-12-14 /pmc/articles/PMC7751777/ /pubmed/33364831 http://dx.doi.org/10.2147/CMAR.S279990 Text en © 2020 Zhou et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Zhou, Jie
Zeng, Zhi Ying
Li, Li
Progress of Artificial Intelligence in Gynecological Malignant Tumors
title Progress of Artificial Intelligence in Gynecological Malignant Tumors
title_full Progress of Artificial Intelligence in Gynecological Malignant Tumors
title_fullStr Progress of Artificial Intelligence in Gynecological Malignant Tumors
title_full_unstemmed Progress of Artificial Intelligence in Gynecological Malignant Tumors
title_short Progress of Artificial Intelligence in Gynecological Malignant Tumors
title_sort progress of artificial intelligence in gynecological malignant tumors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751777/
https://www.ncbi.nlm.nih.gov/pubmed/33364831
http://dx.doi.org/10.2147/CMAR.S279990
work_keys_str_mv AT zhoujie progressofartificialintelligenceingynecologicalmalignanttumors
AT zengzhiying progressofartificialintelligenceingynecologicalmalignanttumors
AT lili progressofartificialintelligenceingynecologicalmalignanttumors